Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 17 de dic. de 2020 · Aortic Stenosis* Aortic Regurgitation Mitral Stenosis Mitral Regurgitation; Progressive (Stage B) Every 35 y (mild severity; V max 2.02.9 m/s) Every 3–5 y (mild severity) Every 3–5 y (MV area >1.5 cm 2) Every 3–5 y (mild severity) Every 1–2 y moderate severity; V max 3.0–3.9 m/s) Every 1–2 y (moderate severity ...

  2. 18 de ago. de 2022 · Aortic valve stenosis is a heart valve disease that narrows the aortic valve and reduces blood flow to the body. Learn about the symptoms, causes and treatment options, including surgery or medication, for different severity levels of aortic valve stenosis.

  3. 16 de abr. de 2023 · When stenosis severity is moderate or symptoms are equivocal, an elevated BNP level can be helpful, but its role in disease progression has not been fully defined. Survival is poor in symptomatic patients, even while the symptoms are mild, unless the outflow obstruction is relieved.

  4. 10 de ene. de 2018 · A precise evaluation of the severity of aortic valve stenosis (AS) is crucial for patient management and risk stratification, and to allocate symptoms legitimately to the valvular disease. Echocardiography is the main method to assess AS severity.

  5. 2 de nov. de 2022 · AAA indicates abdominal aortic aneurysm; AS, aortic stenosis; BAV, bicuspid aortic valve; CAD, coronary artery disease; CoA, coarctation of the aorta; EDS, Ehlers-Danlos syndrome; FTAA, familial thoracic aortic aneurysm (and dissection) syndrome; HTAD, heritable thoracic aortic disease; MV, mitral valve; MVP, mitral valve prolapse ...

  6. 27 de sept. de 2022 · Severe AS is generally defined as significant left ventricular (LV) outflow tract obstruction to cause symptoms (dyspnea, heart failure, chest pain, or syncope) and the criteria for severe AS has evolved over several decades. 1), 2), 3), 4), 5), 6) Although the severity of AS was initially assessed by hemodynamic cardiac catheterization, current...

  7. Aortic stenosis (AS) is the leading primary valvular heart disease in Europe and North America and the second most common cardiovascular disease after arterial hypertension and coronary artery disease [ 1 ]. The prevalence increases with age varying from 0.2 % in the age group 50-59 years to 9.8 % among 80-89 years [ 2 ].